Back to results
US 2014/0179752 A1Published application
Methods of treating soft tissue defects
AssigneeAllergan, Inc.
InventorsDennis E. Van Epps, Guan-Liang Jiang, Wha Bin Im
Life of this patent
Estimating the term…
Abstract
The specification discloses compositions and methods for treating a soft tissue defect of an individual.
Claims14
A method of treating a soft tissue condition of an individual, the method comprising the steps of:
- administering a hydrogel material to the site of the soft tissue condition;
- and
- administering a compound to the site of the soft tissue condition, wherein administration of the compound promotes formation of a blood supply sufficient to support the transplanted tissue, thereby treating the soft tissue site;
- wherein the hydrogel comprises a glycosaminoglycan polymer;
- and
- wherein the compound comprises
- a compound having the structure of formula I,
- wherein each dashed line represents the presence or absence of a bond;
- R1, R2 and R3 are each independently selected from H or C1-6 alkyl;
- R6 is CO2H, CO2R7, CON(R7)2, CONHCH2CH2OH, CON(CH2CH2OH)2, CH2OR7, P(O)(OR7)2,
- R7 is independently H, C1-C6 alkyl or C2-C6 alkenyl;
- X and Y are each independently selected from H, OH, ═O, Cl, Br, I, or CF3;
- Z1 and Z2 are each independently selected from CH or N;
- W1 and W2 are each independently selected from CH, CH2, optionally substituted aryl, or optionally substituted heteroaryl;
- m is 0, 1, 2, 3, 4, 5, or 6;
- o is 0, 1, 2, 3, or 4;
- p is 0or 1;
- and
- V is methyl, optionally substituted aryl, or optionally substituted heteroaryl;
- wherein V is methyl, Z1 or Z2 is N;
- a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable amine salt thereof.
18 more elements
Dependencies are inferred from the claim text.